跳至主要内容
临床试验/PACTR202106791732070
PACTR202106791732070招募中1 期

Pharmacokinetics and pharmacogenomics of Tamoxifen in healthy volunteers: The effects of African specific CYP2D6*17 genotype on the plasma levels of Tamoxifen and its metabolites

AiBST0 个研究点目标入组 42 人开始时间: 2020年5月7日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Male and female subjects aged 18 to 30 years (inclusive).
  • Good health as determined by past medical history, physical examination, vital signs, ECG, and laboratory tests at screening.
  • Be able to communicate and understand the consent process
  • Be of the following CYP2D6 genotypes: CYP2D6*1/*1, CYP2D6*1/*2, CYP2D6*2/*2, CYP2D6*1/*17 and CYP2D6*17/*17
  • BMI between 19 to 27 kg/m2 (inclusive)

排除标准

  • 1. Pregnant women
  • 2. On medication that is known to inhibit CYP2D6 such as antidepressants and antipsychotics
  • 3. Any other CYP2D6 genotypes which are not CYP2D6*1/*1, CYP2D6*1/*2, CYP2D6*2/*2, CYP2D6*1/*17 and CYP2D6*17/*17
  • 4. Breastfeeding women
  • 5. Smokers who report a daily use more than 10 cigarettes
  • 6. Use of prescription drugs or OTC medication
  • 7. Participation in any clinical in

研究者

发起方
AiBST

相似试验

Pharmacokinetics and pharmacogenomics of Tamoxifen... | 临床试验